GJ
Graham Jonathan P Directeur Juridique
Other M
Insider track record Executive Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Graham Jonathan P, Directeur Juridique. Director active across 1 company, notably AMGEN INC. Aggregated, 35 filings have been recorded. Split: 0 buy · 2 sells. Total volume traded: €5.6m. History available since 30 April 2021. The latest transaction was disclosed on 2 May 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations 35 total
● EVP & Gen. Counsel & Sec. · Executives · 2 May 2026 · AMGEN INC 647 shares @ US$329.82 0.0001% mcap 1.1% of flow Common Stock SEC:0000318154-26-000062:0
● EVP & Gen. Counsel & Sec. · Executives · 2 May 2026 · AMGEN INC 610 shares @ US$329.82 0.0001% mcap 1.0% of flow Common Stock SEC:0000318154-26-000062:1
◆ EVP & Gen. Counsel & Secy. · Executives · 6 May 2025 · AMGEN INC 3,180 shares 0Common Stock SEC:0001127602-25-013781:0
● EVP & Gen. Counsel & Secy. · Executives · 2 May 2025 · AMGEN INC 609 shares @ US$283.78 0.9% of flow Common Stock SEC:0001127602-25-013528:0
● EVP & Gen. Counsel & Secy. · Executives · 2 May 2025 · AMGEN INC 592 shares @ US$283.78 0.9% of flow Common Stock SEC:0001127602-25-013528:1
● EVP & Gen. Counsel & Secy. · Executives · 30 Apr 2025 · AMGEN INC 728 shares @ US$288.56 1.1% of flow Common Stock SEC:0001127602-25-013281:0
● EVP & Gen. Counsel & Secy. · Executives · 17 Mar 2025 · AMGEN INC 3,150 shares @ US$313.71 5.4% of flow Common Stock SEC:0001127602-25-010055:0
◆ EVP & Gen. Counsel & Secy. · Executives · 3 Mar 2025 · AMGEN INC 6,306 shares 0Common Stock SEC:0001127602-25-008423:0
◇ EVP & Gen. Counsel & Secy. · Executives · 7 Feb 2025 · AMGEN INC 25,045 shares @ US$156.35 22.6% of flow Common Stock SEC:0001127602-25-003984:0
● EVP & Gen. Counsel & Secy. · Executives · 5 Dec 2024 · AMGEN INC 6,430 shares 0Common Stock SEC:0001127602-24-028802:0
◆ EVP & Gen. Counsel & Secy. · Executives · 7 May 2024 · AMGEN INC 2,863 shares 0Common Stock SEC:0001127602-24-014853:0
● EVP & Gen. Counsel & Secy. · Executives · 5 May 2024 · AMGEN INC 632 shares @ US$311.29 1.1% of flow Common Stock SEC:0001127602-24-014507:0
● EVP & Gen. Counsel & Secy. · Executives · 2 May 2024 · AMGEN INC 591 shares @ US$277.37 0.9% of flow Common Stock SEC:0001127602-24-014192:0
● EVP & Gen. Counsel & Secy. · Executives · 30 Apr 2024 · AMGEN INC 686 shares @ US$276.38 1.1% of flow Common Stock SEC:0001127602-24-014026:0
● EVP & Gen. Counsel & Secy. · Executives · 18 Mar 2024 · AMGEN INC 5,879 shares @ US$268.87 8.7% of flow Common Stock SEC:0001127602-24-010850:0
◆ EVP & Gen. Counsel & Secy. · Executives · 6 Mar 2024 · AMGEN INC 11,760 shares 0Common Stock SEC:0001127602-24-009241:0
▼ EVP, Gen. Counsel & Secy. · Executives · 8 Nov 2023 · AMGEN INC 10,000 shares @ US$272.8136 15.3% of flow Common Stock SEC:0001127602-23-027292:0
● EVP, Gen. Counsel & Secy. · Executives · 1 Nov 2023 · AMGEN INC 1,751 shares @ US$255.70 2.5% of flow Common Stock SEC:0001127602-23-026804:0
● EVP, Gen. Counsel & Secy. · Executives · 5 May 2023 · AMGEN INC 592 shares @ US$231.89 0.7% of flow Common Stock SEC:0001127602-23-015045:0
◆ EVP, Gen. Counsel & Secy. · Executives · 2 May 2023 · AMGEN INC 3,390 shares 0Common Stock SEC:0001127602-23-014607:0
● EVP, Gen. Counsel & Secy. · Executives · 30 Apr 2023 · AMGEN INC 664 shares @ US$239.74 0.9% of flow Common Stock SEC:0001127602-23-014151:0
● EVP, Gen. Counsel & Secy. · Executives · 17 Mar 2023 · AMGEN INC 3,785 shares @ US$234.57 5.0% of flow Common Stock SEC:0001127602-23-010915:0
◆ EVP, Gen. Counsel & Secy. · Executives · 6 Mar 2023 · AMGEN INC 7,560 shares 0Common Stock SEC:0001127602-23-009503:0
● EVP, Gen. Counsel & Secy. · Executives · 1 Nov 2022 · AMGEN INC 1,644 shares @ US$270.35 2.7% of flow Common Stock SEC:0001127602-22-024662:0
● EVP, Gen. Counsel & Secy. · Executives · 12 May 2022 · AMGEN INC 2,000 shares 0Common Stock SEC:0001127602-22-014292:0
25 of 35 declarations
Load more (10 remaining) About Graham Jonathan P Jonathan P. Graham is the General Counsel, Executive Vice President, and Secretary at Amgen Inc. He oversees the company's legal and regulatory affairs. His role is essential for ensuring compliance and managing legal risks. With a strong background in corporate law, he contributes to protecting Amgen's interests.